These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 18160579)

  • 21. [Prevention of vascular complications in polycythemia vera and primary thrombocythemia treated with low doses of acetylsalicylic acid].
    Fröhli P; Graf C; Rhyner K
    Schweiz Med Wochenschr; 1983 Nov; 113(44):1622-7. PubMed ID: 6685916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials.
    Serebruany VL; Steinhubl SR; Berger PB; Malinin AI; Baggish JS; Bhatt DL; Topol EJ
    Am J Cardiol; 2005 May; 95(10):1218-22. PubMed ID: 15877994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of essential thrombocythemia].
    Alvarez-Larrán A; Cervantes F; Besses C
    Med Clin (Barc); 2013 Sep; 141(6):260-4. PubMed ID: 23490491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lower aspirin doses in dual antiplatelet therapy optimise efficacy and safety: CHARISMA follow-up study.
    Cardiovasc J Afr; 2009; 20(3):205. PubMed ID: 19575092
    [No Abstract]   [Full Text] [Related]  

  • 25. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis.
    Cortelazzo S; Finazzi G; Ruggeri M; Vestri O; Galli M; Rodeghiero F; Barbui T
    N Engl J Med; 1995 Apr; 332(17):1132-6. PubMed ID: 7700286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of clopidogrel and acetylsalicylic acid in the prevention of early-phase graft occlusion due to reactive thrombocytosis after coronary artery bypass operation.
    Kayacioglu I; Gunay R; Saskin H; Idiz M; Sensoz Y; Ates M; Tangurek B; Alper AT; Demirtas MM; Yekeler I
    Heart Surg Forum; 2008; 11(3):E152-7. PubMed ID: 18583285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia.
    Squizzato A; Romualdi E; Middeldorp S
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006503. PubMed ID: 18425953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of anagrelide on platelet coagulant function in patients with essential thrombocythemia.
    Cacciola RR; Di Francesco E; Pezzella F; Tibullo D; Giustolisi R; Cacciola E
    Acta Haematol; 2007; 118(4):215-8. PubMed ID: 18057866
    [No Abstract]   [Full Text] [Related]  

  • 29. Plavix isn't for everyone. Adding Plavix to aspirin doesn't help people without heart disease.
    Harv Heart Lett; 2006 Jun; 16(10):1. PubMed ID: 16791939
    [No Abstract]   [Full Text] [Related]  

  • 30. [Introduction to the topic: drug eluting stents. An underestimated problem in surgery].
    Jähne J; Schirren J
    Chirurg; 2009 Jun; 80(6):497. PubMed ID: 19434381
    [No Abstract]   [Full Text] [Related]  

  • 31. Spontaneous abdominal hematoma in a patient treated with clopidogrel and aspirin.
    Otrock ZK; Sawaya JI; Zebian RC; Taher AT
    Ann Hematol; 2006 Oct; 85(10):743-4. PubMed ID: 16821017
    [No Abstract]   [Full Text] [Related]  

  • 32. [Vascular complications of essential thrombocythemia].
    Bellucci S
    Bull Acad Natl Med; 2007 Mar; 191(3):519-30; discussion 530-3. PubMed ID: 18072651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Summaries for patients. What aspirin dose is safest and most effective for preventing heart disease?
    Ann Intern Med; 2009 Mar; 150(6):I-22. PubMed ID: 19293067
    [No Abstract]   [Full Text] [Related]  

  • 34. [A management program for primary thrombocytopenia].
    Knutsen H; Bruserud O
    Tidsskr Nor Laegeforen; 1999 Sep; 119(23):3431-4. PubMed ID: 10553341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?
    Mohler ER
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S1-6. PubMed ID: 19213065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment indications and choice of a platelet-lowering agent in essential thrombocythemia.
    Barbui T; Finazzi G
    Curr Hematol Rep; 2003 May; 2(3):248-56. PubMed ID: 12901347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study.
    Jolly SS; Pogue J; Haladyn K; Peters RJ; Fox KA; Avezum A; Gersh BJ; Rupprecht HJ; Yusuf S; Mehta SR
    Eur Heart J; 2009 Apr; 30(8):900-7. PubMed ID: 18819961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A lower-leg ulcer during hydroxyurea therapy for essential thrombocythemia].
    Iwama H; Kawakubo K; Nehashi Y; Kuriyama Y; Iwase O; Ohyashiki K; Watanabe K; Ebihara Y; Toyama K
    Gan To Kagaku Ryoho; 1996 Jun; 23(7):937-9. PubMed ID: 8678547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Essential thrombocythemia in pregnancy. A case report and general considerations].
    Dell'Isola A; Di Rosa G; Catalano D
    Minerva Ginecol; 1997 Apr; 49(4):165-72. PubMed ID: 9206768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Twice daily aspirin to improve biological aspirin efficacy in patients with essential thrombocythemia.
    Dillinger JG; Sideris G; Henry P; Bal dit Sollier C; Ronez E; Drouet L
    Thromb Res; 2012 Jan; 129(1):91-4. PubMed ID: 22014557
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.